JPRN-UMIN000022613已完成未知
Efficacy of mirabegron for voiding disorders in patient who underwent prostate low-dose-rate brachytherapy - Efficacy of mirabegron in patient treathed with brachytherapy
ara Medical University Department of Urology0 个研究点目标入组 218 人开始时间: 2016年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 218
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •considered unsuitable for the trial by doctors residual urine volume greater than 100 ml Qmax less than 5 ml per second contraindicated to medication with mirabegron history of urinary retention performance of clean intermittent catheterization
研究者
相似试验
进行中（未招募）
1 期
Mirabegron in the management of lower urinary tract symptoms (LUTS) related to double-J (JJ) ureteral stents.Insertion of a JJ stent, prior to extracorporal shock wave lithotripsy (ESWL) and post ureterolithotripsy.MedDRA version: 19.0Level: LLTClassification code 10046707Term: UrolithiasisSystem Organ Class: 100000004857EUCTR2015-004013-25-GRInstitute of Molecular Medicine and Biomedical Research- I.M.B.E.
招募中
4 期
Safety and efficacy of mirabegron on nocturia and quality of sleep in Japanese patients with overactive bladder.overactive bladderJPRN-UMIN000012869Fujita Health University100
已完成
不适用
Examination the efficacy of Mirabegron on patient with overactive bladder after treatment with a1 blocker for benign prostatic hyperplasiaOveractive bladderJPRN-UMIN000019735Department of Urology, Shiga University of medical Science20
已完成
不适用
Mirabegron for catheter related bladder dysfunctioCTRI/2022/05/042735AIIMS Bhubaneswar88
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with cerebrovascular accidentsCTRI/2023/03/050511DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA